Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.82
    -0.54 (-0.65%)
     
  • GOLD FUTURES

    2,337.80
    -4.30 (-0.18%)
     
  • DOW

    38,373.35
    -130.34 (-0.34%)
     
  • Bitcoin GBP

    51,755.28
    -1,778.00 (-3.32%)
     
  • CMC Crypto 200

    1,400.24
    -23.86 (-1.68%)
     
  • NASDAQ Composite

    15,664.27
    -32.37 (-0.21%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Notice of AGM

DXS INTERNATIONAL PLC

Notice of 2022 Annual General Meeting

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems confirms that its Annual General Meeting is scheduled to take place on Thursday 1st December 2022 at 11:30am at the Pavilion Café, Tanshire Park, Shackleford Road, Elstead, Surrey GU8 6LB.

For further information in relation to the AGM shareholders should refer to the Notice of Annual General Meeting and the AGM Letter which have been despatched to shareholders. Copies of these documents, along with the Company's Annual Report for the year ended 30 April 2022, are available for download from the Company's website www.dxs-system.co.uk.

ADVERTISEMENT

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman      (Chief Executive)
DXS International plc

01252 719800
david@dxs-systems.com

Wrecclesham House
Wrecclesham Road
Farnham
Surrey
GU10 4PS

 

www.dxs-systems.co.uk

 


Corporate Advisor

 

David Papworth
City & Merchant

0207 101 7676


Corporate Broker

 

Hybridan LLP
Claire Louise Noyce

020 3764 2341

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.